Literature DB >> 26387430

Molecular shape and immunogenicity of meningococcal polysaccharide group A conjugate vaccine.

Mengfang Xu1, Xueqing Xing2, Zhonghua Wu2, Yuguang Du3, Tao Hu4.   

Abstract

Neisseria meningitidis is a leading cause of severe bacterial infections in infants and young children. As a major virulence factor, meningococcal capsular polysaccharide (PS) is poorly immunogenic and generally does not induce immunological memory. Conjugation of PS with a carrier protein can significantly increase the PS-specific immunogenicity and induce immunological memory. It is well known that the molecular shape/size of the conjugate vaccine is important for its immunogenicity. However, little is known about the molecular shape/size of the meningococcal conjugate vaccine. A meningococcal PS-ovalbumin (OVA) conjugate vaccine was prepared using cystamine as linker. Four components (P1-P4) with different molecular size were fractionated from the conjugate. Small angle X-ray scattering (SAXS) analysis revealed that the conjugate vaccine exhibited a rod-like shape similar to virus-like particles. PS-specific immunogenicity of the conjugate vaccine was related to its molecular shape and increased as a function of its molecular size. Thus, the present study provides a three-dimensional shape of the conjugate vaccine and helps to identify optimal design of a potent meningococcal conjugate vaccine.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Conjugate vaccine; Molecular shape; Neisseria meningitidis; Polysaccharide; SAXS

Mesh:

Substances:

Year:  2015        PMID: 26387430     DOI: 10.1016/j.vaccine.2015.09.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Conjugation of chitosan oligosaccharides via a carrier protein markedly improves immunogenicity of porcine circovirus vaccine.

Authors:  Guiqiang Zhang; Peiyuan Jia; Hongtao Liu; Tao Hu; Yuguang Du
Journal:  Glycoconj J       Date:  2018-07-26       Impact factor: 2.916

2.  The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity.

Authors:  Rui Yu; Junjie Xu; Tao Hu; Wei Chen
Journal:  Mediators Inflamm       Date:  2020-07-04       Impact factor: 4.711

3.  Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine.

Authors:  Rob J Center; Irene Boo; Lilian Phu; Joey McGregor; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.